A novel gene, HA117, was discovered in our previous work. Using the pSOS-HUS vector method which we designed at previous study, we screened for small interfering RNAs (siRNAs) that targeted HA117. The pSOS-HUS siRNA screening results were verified and a delivery system was developed that contained a recombinant adenovirus carrying DNA templates for the transcription of the HA117 siRNAs. Of five pairs of DNA templates, siRNA transcribed from HAi5 produced the strongest effect against HA117. A recombinant adenovirus containing HAi5 (Ad-HAi5) was successfully constructed and evaluated. This work has laid the foundation for further study of HA117 gene function using RNA interference technology and has showed the pSOS-HUS vector method was successfully utilized as a rapid and effective screen of siRNAs for a target gene.
The development of multidrug-resistant tumor cells is a complex process regulated by multiple genes. In a previous study, we established a multidrug-resistant cell line (HL-60/MDR) to facilitate the search for genes involved in the regulation of tumor-cell multidrug resistance. 1 Using a combination of suppression, subtractive hybridization and microarray methods, we screened and cloned the novel gene HA117 (Genbank accession number AY230154) from tumor cells. This gene was clearly expressed in the drug-resistant HL60/MDR cell line but not in the wild-type HL60 cells. We found that it increased the multidrug resistance of K562 cells. We hypothesized that it could be one of the genes regulating tumor cells' drug resistance, and therefore be a new target for cancer gene therapy. 2 RNA interference (RNAi) silencing is a post-transcriptional gene silencing mediated by small interfering antisense RNAs (siRNAs). The main way to screen siRNAs commonly used now is that transfect the synthesized siRNAs or the constructed expression siRNA vectors into experimental cells using Oligofectamine reagents directly, and then compare the difference of gene silencing mediated by different siRNAs. [3] [4] [5] By this way, the expression level and function of the gene have to be examined. The procedure is complex and time consuming. Transfecting the synthesized siRNAs into experimental cells directly can avoid the vector construction, which is relatively simple. But it is expensive to synthesize siRNAs and it is a long time to have the siRNAs custom-made.
In the present study, we used the plasmid-based pSOS-HUS screening system, which was previously developed in our laboratory, to screen for small interfering RNA (siRNA) targeting the HA117 gene. 6 Double-cloned plasmids that contained both the HA117 gene and DNA templates were constructed for complementary siRNAs. After transfection of these plasmids into HEK-293 cells, we screened for and identified an optimal siRNA against the HA117 gene. siRNA effectiveness was measured by green fluorescent protein (GFP) expression levels using microscopic observation and flow cytometry and by quantitating HA117 mRNA expression by reverse-transcription qPCR (RT-qPCR). A recombinant adenovirus for HA117 RNAi was also constructed and evaluated in CW-2 cells (human colon carcinoma cell line).
Materials and methods

Plasmids and cell lines
The screening plasmid pSOS-HUS and a red fluorescent protein-carrying adenovirus backbone plasmid (pSES-HUS) were developed in collaboration with the Molecular Oncology Laboratory at the University of Chicago. E. coli DH5a, E. coli BJ5183, BJ5183-derivative Adeasy-1 cells, the adenoviral genome carrying plasmid pAdeasy-1 and the packaging cell line 293 were generous gifts from Professor Tong-Chuan He of the Molecular Oncology Laboratory at the University of Chicago. The recombinant plasmid containing HA117, pAdtrack-HA117, and the recombinant adenovirus containing HA117, Ad5-HA117, were propagated in our laboratory. 4 The human colon carcinoma cells CW-2 were bought from the Cell Bank of the Chinese Academy of Science, Shanghai, China.
Reagents
Restriction endonucleases, T4 DNA ligase, plasmid DNA isolation, extraction and purification kits and RT-PCR kits were all purchased from TaKaRa Bio, Dalian, China. Lipofectamine and an RNA extraction kit were purchased from Invitrogen Corporation, San Diego, CA. DNA templates for HA117 gene siRNAs and PCR primers were synthesized by TaKaRa Bio. DNA sequencing was conducted by the Laboratory of Infectious Diseases at Chongqing Medical University. High-quality fetal bovine serum and RPMI 1640 medium were Gibco (San Diego, CA) products.
Construction of recombinant plasmid pSOS-HUS-HA117
The plasmids pAdTrack-HA117 and pSOS-HUS were double digested with HindIII and KpnI restriction endonucleases. The excised target gene, HA117, and the linearized pSOS-HUS vector were extracted from an agarose gel after digestion. They were then purified, ligated with T4 DNA ligase and transformed into competent DH5a cells. Colonies were picked and amplified for plasmid DNA preparation and restriction digestion. Positive clones were identified by restriction digestion and further confirmed by sequencing.
Design and synthesis of DNA templates for HA117 siRNA Using the principles of siRNA design and the fulllength cDNA sequence of the HA117 gene, 5 we designed and synthesized specific HA117 gene-insertion-fragment sequences as described below. Construction and identification of the pSOS-HUS-HA117 and HAi recombinant plasmids The plasmid pSOS-HUS-HA117 was digested with SfiI, ligated to the five pairs of template DNA with T4 DNA ligase and transformed into DH5a-competent cells. Colonies were picked and amplified for plasmid DNA preparation and restriction digestion. Positive clones were identified by restriction digestion and further confirmed by sequencing.
Transfection of the double-cloned plasmids into 293 cells with Lipofectamine
The plasmid pSOS-HUS-HA117 and the five positive double-cloned plasmids were extracted and dissolved in a final volume of 30 ml. The OD values at 260 nm of the samples of HAi1-HAi5 measured by spectrophotometer were 7.78, 7.32, 9.45, 8.33, 7.96 and 8.57, respectively. The method of transfection required 4 mg of plasmid DNA; therefore, the necessary aliquots of plasmids HAi1-HAi5 were 10.5, 11, 8.5, 9.7, 10 and 9.6 ml. The packaging 293 cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum and incubated at 37 1C under 5% CO 2 . Exponentially growing cells were seeded into six 50 ml cell culture flasks to 50-60% confluency. The 293 cells were incubated for 14 h before being transfected using Lipofectamine with the recombinant pSOS-HUS-HA117 plasmid or one of the five double-cloned plasmid 
Evaluation of HA117 gene silencing by the recombinantRNAi adenovirus Ad-HAi5. The CW-2 cells were infected with the recombinant adenovirus carrying the HA117 gene. At 24 h post-infection, the cells were divided into two groups, a control group and an RNAi group. The RNAi group of CW-2 cells was infected with the recombinant adenovirus carrying siRNA. The CW-2 cells not infected with recombinant adenovirus were used as a control. After 48 h of incubation, the two groups of cells were harvested, their total RNA was extracted and the cellular HA117 mRNA expression levels were determined by RT-qPCR.
Statistical analysis
The experimental data were subjected to analysis of variance, with a Po0.05 considered statistically significant.
Results
Restriction digestion of recombinant plasmid pSOS-HUS-HA117
The successfully constructed recombinant plasmid pSOS-HUS-HA117 was double digested with HindIII and KpnI. The circular plasmid was cleaved into a 4.9-kb pSOS-HUS DNA fragment and a 1.19-kb HA117 gene fragment, as shown in Figure 1 .
Restriction digestion of the double-cloned pSOS-HUS-HA117-HAi plasmid
The plasmid pSOS-HUS has a SfiI restriction site between the U6 and H1 promoters. This site is lost after SfiI digestion and HAi fragments cloned into this site do not have the SfiI restriction site. Therefore, positive plasmid clones cannot be digested with SfiI. 6 As shown in Figure 2 , the double-cloned pSOS-HUS-HA117-HAi1 plasmid was digested with SfiI and the uncut, supercoiled-plasmid DNA band could be seen after electrophoresis. HindIII and KpnI double digestion of pSOS-HUS-HA117-HAi1 released a 1.19-kb HA117 band and a 4.9-kb vector band. These results indicated that pSOS-HUS-HA117-HAi1 carried both the HA117 gene and the HAi1 RNAi fragment.
Sequence verification of the double-cloned plasmids All five positive double-cloned plasmids were submitted for DNA sequencing. The U6 promoter on the plasmid was used as the starting point to sequence the DNA. Figure 3 confirmed that the sequences between the H1 and U6 promoters corresponded to the HAi sequences and the five double-cloned plasmids were successfully constructed.
Relative GFP expression levels in transfected 293 cells HEK-293 cells were transfected with an equal amount of pSOS-HUS or pSOS-HAi plasmids. The transfected 293 cells were observed and compared at 24 h post-transfection. As shown in Figure 4a , the green fluorescence was the weakest in the 293 cells transfected with the HAi5-containing plasmid. All groups of cells were harvested to examine, using flow cytometry, the percentage of GFPexpressing cells. The 293 cells transfected with the HAi5-containing double-cloned plasmid had the lowest ratio of GFP expression, which was consistent with the fluorescence-microscopy results, as shown in Figure 4b . These results suggested that the siRNA transcribed from HAi5 had the strongest ability to interfere with HA117.
Results of recombined adenovirus Ad5-HAi5 construction After HAi5 was cloned into the adenovirus backbone plasmid pSES-HUS, it was cotransformed with the adenovirus homologous shuttle plasmid Adeasy for recombination. A successful recombination event should generate 4.5 kb and 23 kb DNA bands following digestion with PacI. The results shown in Figure 5a The results of evaluation of HA117 gene silencing by the optimal siRNA and the recombinant-RNAi adenovirus Ad-HAi5 HA117 mRNA expression in the transfected 293 cells. At 24 h after transfection, the six groups of transfected 293 cells were harvested and the HA117 mRNA expression levels were determined by RT-PCR. The PCR products were separated by 2% agarose gel electrophoresis and visualized with a UV transilluminator. The HA117 mRNA expression level was the lowest in the group of 293 cells that were transfected with pSOS-HUS-HA117-HAi5. At 24 hours post-transfection, the six groups of 293 transfected cells were harvested and the HA117 mRNA expression levels in the different groups were determined by RT-PCR. As shown in Figure 6a , the HA117 mRNA expression level was the lowest in the group of 293 cells transfected with pSOS-HUS-HA117-HAi5, suggesting that the siRNA transcribed from HAi5 had the strongest ability to interfere with HA117 gene expression.
The Ad-HAi5 recombinant adenovirus effectively silences HA117 gene expression. CW-2 cells are highly susceptible to the recombinant adenoviruses Ad-HA117 and Ad-HAi5. At 48 h post-infection, green fluorescence was observed in CW-2 cells infected with Ad-HA117. At 24 h after Ad-HA117 infection, the infected CW-2 cells were superinfected with Ad-HAi5. After superinfection, both green and red fluorescence were observed simultaneously, as shown in Figure 6b .
All groups of cells were harvested after 48 h and analyzed by RT-qPCR. As shown in Figure 6c , the Ad-HA117 infected control cells exhibited a 119-bp DNA band characteristic of the HA117 gene, while the cells infected with Ad-HA117 then superinfected with Ad-HAi5 did not exhibit the DNA band for the HA117 gene. This result suggested that the HA117-targeting RNAi successfully silenced the exogenous HA117 gene expression in the CW-2 cells.
Discussion
RNAi silencing is a post-transcriptional gene silencing mediated by siRNAs. It features high specificity, high efficiency and inheritability and it is an effective method for studying gene function. 7, 8 The siRNA antisense strand must be strict base pairing with its target gene. Even one mispairing of base can reduce the silence effects greatly. 9 It is very crucial to select both efficient suppression characteristic and conservative siRNA target sites. But even if the siRNAs are strictly followed the principle of siRNA design, 10, 11 there is only 60-70% of them can have a gene silence effects. Currently, siRNAs are usually designed based on the software analysis or literature study. Different softwaredesigned siRNAs targeting the same gene may have different interference efficiencies. [9] [10] [11] If the most efficient siRNA can be quickly and easily screened from among many siRNAs, this would greatly facilitate successful silencing of target gene expression with RNAi. This capability would be especially helpful in the study of novel gene function.
The convenient and effective siRNA screening plasmid (pSOS-HUS) used in this study is a vector system designed to express small RNA fragments such as RNAi and was developed by our group in collaboration with the Cancer Research Institute at the University of Chicago. The siRNA for RNAi can be obtained by in vitro preparation (such as chemical synthesis), in vitro transcription or by digesting a large dsRNA fragment using RNase III. It can also be obtained by in vivo synthesis through siRNA expression using plasmid or viral vectors, or through a siRNA expression cassette prepared by PCR. 12 Among these cassettes, the adenoviral vector for intracellular siRNA expression is convenient and inexpensive, making it one of the most widely used biological viral vectors. It has many advantages, including a wide host range, low pathogenicity for humans and effective proliferation. [13] [14] [15] [16] Here, we used the adenoviral shuttle plasmid pSES-HUS to design a double promoter containing a SfiI restriction site. Upon insertion of the siRNA transcription template of the target gene into this site, the siRNA can be made. Based on this shuttle plasmid and the adenoviral backbone plasmid, a recombinant-RNAi adenovirus was constructed for the target gene. After infecting the cells, the siRNA for the target gene was stably expressed for a long period of time as it executed its RNAi function.
Using the screening plasmid pSOS-HUS, we successfully identified the strongest-interfering siRNA (HAi5) from among five siRNA transcription templates for the target gene HA117. We constructed a HAi5-carrying recombinant adenovirus (Ad-HAi5) to target HA117 using the modified adenovirus shuttle plasmid pSES-HUS. Subsequent functional analysis showed that Ad-HAi5 effectively silenced HA117 gene expression through RNAi. This study thus established a framework for further functional studies of the novel gene HA117 using RNAi. Additionally, our results showed that pSOS-HUS is a quick and convenient screening system for selecting the best siRNA transcription template for a target gene.
